Central America vs Turkmenistan: Proportion of the target population who received the final dose of
Central America
79.0%
in 2024
Turkmenistan
99.0%
in 2024
Central America rank
1st
Turkmenistan rank
1st
Proportion of the target population who received the final dose of over time
- Central America
- Turkmenistan
How they compare
Turkmenistan currently reports 99.0% against 79.0% in Central America, a difference of 20.0%.
That makes Turkmenistan's figure about 1.3 times Central America's.
Across all 8 years both countries report, Turkmenistan has been ahead every year.
Central America ranks 1st and Turkmenistan ranks 1st of 35 groups.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central America | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.0% | 94.7% | 21.7% | Turkmenistan |
| 2020s | 47.6% | 98.6% | 51.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central America or Turkmenistan?
- Turkmenistan, at 99.0% against 79.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central America and Turkmenistan?
- 20.0%, with Turkmenistan ahead.
- How many years of comparable data are there for Central America and Turkmenistan?
- 8 years are reported by both, from 2017 to 2024.
- How do Central America and Turkmenistan rank globally for proportion of the target population who received the final dose of?
- Central America ranks 1st and Turkmenistan ranks 1st of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.